Clinical Trial Update: Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating clopidogrel in high-risk patients with acute non-disabling cerebrovascular events has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Stroke, Transient Ischemic Attack | Phase 3 | Status: COMPLETED